2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone

C113H126N24O10S4 — CID 161032425

IUPAC2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone
SMILESCCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3c(C)nn(C)c3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3ccnn3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3cn(C)cc3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3cnc(C)n3C)n2n1.COc1ccc(-c2cc(-c3cccn3C)n3nc(C(=O)N4CCCCC4)cc3n2)cc1
InChIInChI=1S/C24H25N5O2.C23H27N5O2S.C23H26N4O2S.C22H25N5O2S.C21H23N5O2S/c1-27-12-6-7-21(27)22-15-19(17-8-10-18(31-2)11-9-17)25-23-16-20(26-29(22)23)24(30)28-13-4-3-5-14-28;1-6-7-12-31(29)22-14-21-24-19(17-8-10-18(30-5)11-9-17)13-20(28(21)26-22)23-15(2)25-27(4)16(23)3;1-5-6-11-30(28)23-13-22-24-20(17-7-9-18(29-4)10-8-17)12-21(27(22)25-23)19-15-26(3)14-16(19)2;1-5-6-11-30(28)22-13-21-24-18(16-7-9-17(29-4)10-8-16)12-19(27(21)25-22)20-14-23-15(2)26(20)3;1-4-5-12-29(27)21-14-20-23-17(15-6-8-16(28-3)9-7-15)13-19(26(20)24-21)18-10-11-22-25(18)2/h6-12,15-16H,3-5,13-14H2,1-2H3;8-11,13-14H,6-7,12H2,1-5H3;7-10,12-15H,5-6,11H2,1-4H3;7-10,12-14H,5-6,11H2,1-4H3;6-11,13-14H,4-5,12H2,1-3H3
InChIKeyTZUJRLVZRQDNDH-UHFFFAOYSA-N
MW2108.68 g/mol
LogP20.73
Rot. Bonds32

About 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone

2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone (PubChem CID 161032425) has the molecular formula C113H126N24O10S4 and a molecular weight of 2108.68 g/mol. Its IUPAC name is 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone.

Molecular Properties

Compound Name2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone
PubChem CID161032425
Molecular FormulaC113H126N24O10S4
Molecular Weight2108.68 g/mol
Exact Mass2106.90
IUPAC Name2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone
SMILESCCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3c(C)nn(C)c3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3ccnn3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3cn(C)cc3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3cnc(C)n3C)n2n1.COc1ccc(-c2cc(-c3cccn3C)n3nc(C(=O)N4CCCCC4)cc3n2)cc1
InChIInChI=1S/C24H25N5O2.C23H27N5O2S.C23H26N4O2S.C22H25N5O2S.C21H23N5O2S/c1-27-12-6-7-21(27)22-15-19(17-8-10-18(31-2)11-9-17)25-23-16-20(26-29(22)23)24(30)28-13-4-3-5-14-28;1-6-7-12-31(29)22-14-21-24-19(17-8-10-18(30-5)11-9-17)13-20(28(21)26-22)23-15(2)25-27(4)16(23)3;1-5-6-11-30(28)23-13-22-24-20(17-7-9-18(29-4)10-8-17)12-21(27(22)25-23)19-15-26(3)14-16(19)2;1-5-6-11-30(28)22-13-21-24-18(16-7-9-17(29-4)10-8-16)12-19(27(21)25-22)20-14-23-15(2)26(20)3;1-4-5-12-29(27)21-14-20-23-17(15-6-8-16(28-3)9-7-15)13-19(26(20)24-21)18-10-11-22-25(18)2/h6-12,15-16H,3-5,13-14H2,1-2H3;8-11,13-14H,6-7,12H2,1-5H3;7-10,12-15H,5-6,11H2,1-4H3;7-10,12-14H,5-6,11H2,1-4H3;6-11,13-14H,4-5,12H2,1-3H3
InChIKeyTZUJRLVZRQDNDH-UHFFFAOYSA-N
XLogP20.73
TPSA349.01 Ų
H-Bond Donors
H-Bond Acceptors33
Rotatable Bonds32
Heavy Atoms151
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002108.68
LogP ≤ 520.73
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1033

Analyze 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone?
The IUPAC name of 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone (CID 161032425) is 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone.
What is the SMILES notation for 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone?
The canonical SMILES for 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone is CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3c(C)nn(C)c3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3ccnn3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3cn(C)cc3C)n2n1.CCCCS(=O)c1cc2nc(-c3ccc(OC)cc3)cc(-c3cnc(C)n3C)n2n1.COc1ccc(-c2cc(-c3cccn3C)n3nc(C(=O)N4CCCCC4)cc3n2)cc1.
What is the InChIKey of 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone?
The InChIKey is TZUJRLVZRQDNDH-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H25N5O2.C23H27N5O2S.C23H26N4O2S.C22H25N5O2S.C21H23N5O2S/c1-27-12-6-7-21(27)22-15-19(17-8-10-18(31-2)11-9-17)25-23-16-20(26-29(22)23)24(30)28-13-4-3-5-14-28;1-6-7-12-31(29)22-14-21-24-19(17-8-10-18(30-5)11-9-17)13-20(28(21)26-22)23-15(2)25-27(4)16(23)3;1-5-6-11-30(28)23-13-22-24-20(17-7-9-18(29-4)10-8-17)12-21(27(22)25-23)19-15-26(3)14-16(19)2;1-5-6-11-30(28)22-13-21-24-18(16-7-9-17(29-4)10-8-16)12-19(27(21)25-22)20-14-23-15(2)26(20)3;1-4-5-12-29(27)21-14-20-23-17(15-6-8-16(28-3)9-7-15)13-19(26(20)24-21)18-10-11-22-25(18)2/h6-12,15-16H,3-5,13-14H2,1-2H3;8-11,13-14H,6-7,12H2,1-5H3;7-10,12-15H,5-6,11H2,1-4H3;7-10,12-14H,5-6,11H2,1-4H3;6-11,13-14H,4-5,12H2,1-3H3.
What are the key properties of 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone?
2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone has a molecular weight of 2108.68 g/mol, XLogP of 20.73, 32 rotatable bonds, 0 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 2-butylsulfinyl-7-(2,3-dimethylimidazol-4-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-7-(1,4-dimethylpyrrol-3-yl)-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(2-methylpyrazol-3-yl)pyrazolo[1,5-a]pyrimidine;2-butylsulfinyl-5-(4-methoxyphenyl)-7-(1,3,5-trimethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidine;[5-(4-methoxyphenyl)-7-(1-methylpyrrol-2-yl)pyrazolo[1,5-a]pyrimidin-2-yl]-piperidin-1-ylmethanone is sourced from PubChem (CID 161032425), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).